Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Bisogno, Gianni, De Salvo, Gian Luca, Bergeron, Christophe, Gallego Melcón, Soledad, Merks, Johannes H, Kelsey, Anna, Martelli, Helene, Minard-Colin, Veronique, Orbach, Daniel, Glosli, Heidi, ChisholmLangue:
english
Journal:
The Lancet Oncology
DOI:
10.1016/s1470-2045(19)30617-5
Date:
September, 2019
Fichier:
PDF, 273 KB
english, 2019
File converter
Plus de résultats de recherche
More benefits 
